Erratum: Herpes zoster-attributable resource utilization and cost burden in patients with solid organ transplant (Transplantation (2014) 97 (1178)) DOI: 10.1097/01.tp.0000441826.70687.f6);Herpes zoster-Attributable resource utilization and cost burden in patients with solid organ transplant

Transplantation

Volumn 97, Issue 11, 2014, Pages 1178-1184

  Palmer, Liisa ^a   White, Ronald R ^b   Johnson, Barbara H ^a   Fowler, Robert ^a   Acosta, Camilo J ^b  

^a IBM WATSON HEALTH   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cost analysis; Herpes zoster; Immunocompromise; Resource use; Solid organ transplant.

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST UTILITY ANALYSIS; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HERPES ZOSTER; HOSPITAL ADMISSION; HOSPITALIZATION COST; HUMAN; IMMUNOCOMPROMISED PATIENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MIDDLE AGED; NONHUMAN; ORGAN TRANSPLANTATION; OUTPATIENT CARE; PRIORITY JOURNAL; RESOURCE MANAGEMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HERPES ZOSTER; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, HEALTH; MALE; MEDICAID; MEDICARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGAN TRANSPLANTATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84902120514     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000703     Document Type: Erratum

References (14)

1. CDC. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57: 1.
2. Insinga RP, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen InternMed 2005; 20: 748.
3. Wood MJ, Easterbrook P. Shingles, scourge of the elderly: the acute illness. In: Sacks SL, Straus SE, Whitley RJ, et al, eds. Clinical Management of Herpes Zoster. Washington, DC: IOS Press; 1995: 193-209.
4. Gourishandar S, McDermid JC, Jhangri GS, et al. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004; 4: 108.
5. Luby JP, Ramirez-Ronda C, Rinner S, et al. A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis 1977; 135: 659.
6. Rand KH, Rasmussen LE, Pollard RB, et al. Cellular immunity and herpes virus infections in cardiac-Transplant patients. N Engl J Med 1977; 296: 1372.
7. White RR, Lenhart G, Singhal PK, et al. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics 2009; 27: 781.
8. Insinga RP, Itzler RF, Pellissier JM. Acute/subacute herpes zoster. Healthcare resource utilisation and costs in a group of US health plans. Pharmacoeconomics 2007; 25: 155.
9. Unterman S, Zimmerman M, Tyo C, et al. A descriptive analysis of 1251 solid organ transplant visits to the emergency department. West JEM 2009; 10: 48.
10. Drolet M, Brisson M, Levin MJ, et al. A prospective study of the herpes zoster severity of illness. Clin J Pain 2010; 26: 656.
11. Yawn BP, Itzler RF, Wollan PC, et al. Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc 2009; 84: 787.
12. Dworkin RH, White R, OConnor AB, et al. Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster. JAGS 2007; 55: 1168.
13. Helgason S, Sigurdasson JA, Gudmundsson S. The clinical course of herpes zoster: a prospective study in primary care. Eur J Gen Pract 1996; 2: 12.
14. Scott FT, Johnson RW, Leedham-Green M, et al. The burden of herpes zoster: a prospective population based study. Vaccine 2006; 24: 1308.